首页 › 结直肠癌 › 加利福尼亚州

加利福尼亚州的结直肠癌临床试验

加利福尼亚州有 136 项针对结直肠癌的研究正在招募参与者。

加利福尼亚州的城市

官方研究文本（英文）

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

City of Hope, Duarte
Hoag Memorial Hospital Presbyterian, Newport Beach

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT07544589

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

招募中欢迎健康志愿者

45 至 75 岁 · 所有性别 · 更新于 2026年10月5日 · NCT06995898

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

START Los Angeles, Los Angeles
Valkyrie Clinical Trials (contact for more locations), Los Angeles

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT07659795

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

City of Hope National Medical Center /ID# 279449, Duarte

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07525206

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Jennifer Moreno Department of Veterans Affairs Medical Cneter, San Diego
Kaiser Permanente Northern California, Walnut Creek

招募中

65 至 82 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05612347

Family Communications After Genetic Testing

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
Marshall Cancer Center, Cameron Park
以及另外 17 项

招募中欢迎健康志愿者

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07143487

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT06760819

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Tower Cancer Research Foundation, Beverly Hills
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Cedars-Sinai Medical Center, Los Angeles
以及另外 1 项

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
以及另外 20 项

招募中观察性研究欢迎健康志愿者

40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #59, Santa Barbara

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Oncology Institute of Hope and Innovation, Cerritos
Ellison Medical Institute, Los Angeles
Valkyrie Clinical Trials, Los Angeles
以及另外 3 项

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 9, La Jolla
ALX Center 11, Santa Monica

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
以及另外 1 项

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT05877599

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

UCSF at Berkeley Outpatient Center, Berkeley
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
UCSD Medical Center - Encinitas, Encinitas
以及另外 21 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
USC Norris Comprehensive Cancer Center, Los Angeles

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT05482893

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

City of Hope National Medical Center /ID# 270255, Duarte
UCLA - Santa Monica /ID# 270621, Santa Monica

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT06820463

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

UCLA ( Site 0317), Los Angeles

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

CBCC Global Research, Bakersfield
Los Angeles Cancer Network, Glendale
Cancer and Blood Specialty Clinic, Los Alamitos
以及另外 4 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06750094

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

City of Hope Comprehensive Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07271355

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

招募中观察性研究

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT04981119

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

University of California, Los Angeles UCLA, Los Angeles

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT05379595

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06218914

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

CBCC Global Research, Bakersfield
Los Angeles Cancer Network, Glendale
Cancer and Blood Specialty Clinic, Los Alamitos
以及另外 4 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06662786

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

City of Hope Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine
START Los Angeles, Los Angeles

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06004245

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT06047379

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT07229313

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

UC Irvine Health Cancer Center-Newport, Costa Mesa
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
USC / Norris Comprehensive Cancer Center, Los Angeles
以及另外 1 项

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT06102902

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

USC/Norris Comprehensive Cancer Center, Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Local Institution - 0317, San Francisco

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07221357